What does liraglutide cost in each channel?
Prices in US dollars at the verification date. Ranges are published list or program prices where a primary source exists; notes say when a figure is a typical market range instead.
| Channel | Price (USD) | Notes |
|---|---|---|
| With insurance | From $25per month | When a commercial plan covers Saxenda, the manufacturer savings card lets eligible patients pay as little as $25, or save up to $200 per prescription, for up to 12 months (checked 2026-09-22); otherwise the plan copay applies. Medicare Part D covers liraglutide for type 2 diabetes but generally not when prescribed only for weight loss, and the Medicare GLP-1 Bridge demonstration that began July 1, 2026 covers other weight management GLP-1 drugs but not liraglutide. [3] [11] [12] |
| List price for type 2 diabetes | $544 to $815per month | Manufacturer wholesale acquisition cost for Victoza (type 2 diabetes), checked 2026-09-22: $543.51 for the 2-pen pack, which is a 30 day supply at 1.2 mg daily, and $815.27 for the 3-pen pack, which is a 30 day supply at 1.8 mg daily. Retail pharmacies may add a margin. [1] [6] |
| List price for weight management | $1,349per month | Manufacturer list price for Saxenda (chronic weight management), checked 2026-09-22: $1,349.02 per 5-pen package, a 30 day supply at the 3 mg maintenance dose. [2] [3] [7] |
| Generic cash price | $112 to $924per month | Generic liraglutide cash prices from a published discount-card price source, checked 2026-09-22 (prices updated that day): a 2-pen carton (30 days at 1.2 mg daily) from about $112 with a discount card against an average retail price of about $616; a 3-pen carton (30 days at 1.8 mg daily) from about $154 with a discount card against about $924 at retail; and a 5-pen carton of the 3 mg weight management generic from about $372 with a discount card against about $700 at retail. Individual pharmacies can charge more. Generics referencing Victoza were first approved in December 2024. [4] [5] [8] |
| Compounded pharmacy | Not published | No dated lawful price was found for a compounded product. FDA's Drug Shortages database lists liraglutide injection as in shortage as of September 27, 2026, with Victoza and Saxenda presentations at limited availability, and lists Saxenda (NDC 0169-2800-15) as To Be Discontinued, posted August 25, 2026. FDA states that a compounded drug may not be identical or nearly identical to an FDA-approved drug unless the approved drug is on FDA's drug shortage list. Generic liraglutide is also marketed. Ask any pharmacy offering compounded liraglutide which FDA rule it relies on. [8] [9] [10] [13] [14] |
What is the list price of liraglutide?
List prices are manufacturer wholesale acquisition costs. Victoza is priced per pen pack ($543.51 for 2 pens, $815.27 for 3 pens), so the monthly cost depends on the daily dose; Saxenda is $1,349.02 per five-pen package. Generic pens sell for a fraction of brand list with a discount card.
Does insurance cover liraglutide?
Coverage follows the indication. Victoza and generic liraglutide for type 2 diabetes are widely covered, including by Medicare Part D. Saxenda for weight management is excluded by many employer plans and by Part D when prescribed for weight loss alone; a generic may be required before the brand. Liraglutide is not among the drugs covered by the Medicare GLP-1 Bridge demonstration.
What changes the price?
- Indication on the prescription (type 2 diabetes versus weight management)
- Daily dose, which sets how many pens a month requires
- Brand versus generic pen
- Pharmacy and discount card used for cash purchases
- Manufacturer savings card eligibility with commercial insurance
Frequently asked questions
How much does liraglutide cost without insurance?
About $112 to $1,349 per month at the verification date, depending on the channel: list price for type 2 diabetes, list price for weight management, generic cash price. See the table above for what each figure includes. [1] [2] [3] [4] [5] [6] [7] [8]
Does insurance cover liraglutide?
Coverage follows the indication. Victoza and generic liraglutide for type 2 diabetes are widely covered, including by Medicare Part D. Saxenda for weight management is excluded by many employer plans and by Part D when prescribed for weight loss alone; a generic may be required before the brand. Liraglutide is not among the drugs covered by the Medicare GLP-1 Bridge demonstration. [3] [11] [12]
What is the list price of liraglutide?
List prices are manufacturer wholesale acquisition costs. Victoza is priced per pen pack ($543.51 for 2 pens, $815.27 for 3 pens), so the monthly cost depends on the daily dose; Saxenda is $1,349.02 per five-pen package. Generic pens sell for a fraction of brand list with a discount card. [1] [2] [3] [4] [5] [6] [7] [8]
Related pages
- Liraglutide: evidence, legality, and access
- Liraglutide vs cagrilintide
- Liraglutide vs dulaglutide (Dulaglutide cost)
- Liraglutide vs exenatide (Exenatide cost)
- Liraglutide vs setmelanotide
- Semaglutide vs liraglutide (Semaglutide cost)
- Tirzepatide vs liraglutide (Tirzepatide cost)
- Obesity and chronic weight management: peptide evidence
- Type 2 diabetes: peptide evidence
- Cardiovascular risk reduction: peptide evidence
- Chronic kidney disease: peptide evidence
- Insulin resistance and prediabetes: peptide evidence
- Where it is legal to get: peptide law by state
- Full cost index
Sources
- [1]Manufacturer list price (wholesale acquisition cost) page for liraglutide for type 2 diabetes, 2-pen and 3-pen packs, accessed 2026-09-222026
- [2]Manufacturer list price (wholesale acquisition cost) page for liraglutide 3 mg for weight management, accessed 2026-09-222026
- [3]Manufacturer list price and savings card explainer for liraglutide 3 mg for weight management, accessed 2026-09-222026
- [4]Published cash-price comparison for generic liraglutide 18 mg/3 mL pens (diabetes strength), discount-card and average retail prices, accessed 2026-09-222026
- [5]Published cash-price comparison for generic liraglutide 3 mg pens (weight management), discount-card and average retail prices, accessed 2026-09-222026
- [6]FDA prescribing information for Victoza (liraglutide) injection, via DailyMedFDA
- [7]FDA prescribing information for Saxenda (liraglutide) injection, via DailyMedFDA
- [8]FDA: First generic drug approvals (includes liraglutide injection, December 2024)FDA
- [9]FDA: Compounding and the FDA, questions and answersFDA
- [10]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA